Representative Functional Connectivity Learning for Multiple Clinical groups in Alzheimer's Disease
Lu Zhang, Xiaowei Yu, Yanjun Lyu, Li Wang, Dajiang Zhu

TL;DR
This paper introduces a deep learning model that learns representative functional connectivity patterns for different clinical groups in Alzheimer's disease, achieving high classification accuracy between healthy, MCI, and AD groups.
Contribution
It proposes an integrated autoencoder and multi-class classifier model to identify group-specific functional connectivity features in Alzheimer's disease progression.
Findings
Achieved 68% accuracy in classifying five clinical groups.
Learned representative FC patterns for each clinical group.
Demonstrated the model's effectiveness in distinguishing MCI subtypes.
Abstract
Mild cognitive impairment (MCI) is a high-risk dementia condition which progresses to probable Alzheimer's disease (AD) at approximately 10% to 15% per year. Characterization of group-level differences between two subtypes of MCI - stable MCI (sMCI) and progressive MCI (pMCI) is the key step to understand the mechanisms of MCI progression and enable possible delay of transition from MCI to AD. Functional connectivity (FC) is considered as a promising way to study MCI progression since which may show alterations even in preclinical stages and provide substrates for AD progression. However, the representative FC patterns during AD development for different clinical groups, especially for sMCI and pMCI, have been understudied. In this work, we integrated autoencoder and multi-class classification into a single deep model and successfully learned a set of clinical group related feature…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDementia and Cognitive Impairment Research · Alzheimer's disease research and treatments · Neurological Disease Mechanisms and Treatments
